VRTXLong VRTX 🚀📊 It is not financial advice. This is my opinion. Please check yourselves and invest in the symbols in which you think have a huge opportunity to reach the best results. please leave us your opinions and reviews here.🙏🙂 Good Luck 👍😉Longby am763Updated 112
Vertex, a great pharmaceutical at a discounted priceA company with over 10 years of consistent and constant growth, a wide coverage of products already on the market and... despite an excellent quarterly for a news or a trail .. boom .. It drops suddenly ? In my opinion this is sheer market madness, the sites I use as a reference for fundamental analysis confirm to me what I say, the company always be more than 50% below its fair value. To confirm my conviction is also Market Miracle the algorithmic advisor, which has provided an entry signal on the stock at the price of 188 usd, also providing a valuable indication ... that is, that the price of the stock is in the area of oversold. In the immediate I don’t expect a great climb but given the solidity of the company is definitely a low-risk investment that, given the discounted price can also lead to very interesting gains in the medium term ... obviously if the price starts to rise. So I decided to increase the positions on Vertex Pharmaceuticals $VRTX hoping to be on the side of the market that as you know always has the reason on its side. This idea is based on a signal generated by the advisor Marketmiracle, down on this page you will find the link to the page of signals of the advisor that you can see for free without any cost or registrationLongby MarketMiracleAdvisorUpdated 2
Long | VRTXNASDAQ:VRTX Possible Scenario: LONG Evidence: Price Action TP1: 219$ TP2: 225$ TP3: 247$ TP4: 270$ Call options, Strike 230$, 06/18/21 *This is my idea and could be wrong 100%Longby shksprUpdated 220
VRTX longVRTX is close to previous support and lows of 2020. Looks like it is safe to buy.Longby financialSnail88674223
VRTXHey investors, this is a good opportunity to invest in VRTX under the fair valueLongby LukeMading2
Vertex intrinsic value estimationVertex at this time is a cash machine and seam undervalued according to DCF model. but everything depend on future treatment development so there is ah high value of volatility and risk related to this company. Long04:29by viveredidividendi6
Daily Squeeze PlayCarter's Squeeze Play setup. A daily squeeze has been building up for quite a few days. Which direction will it break to? Longby seariverunlimited3
$VRTX Clean set up.As easy as it gets. First target 240. (200DMA and 0,618 FIBO ext.) If market strong it will be able to blast through it.Longby TISSENBELGIUM1
Best Biotech to buy right now.Long-term investing. Probably one of the best ideas among the largest biotech companies. Buy @ $200-210, TP $300-500.Longby Heist_FlyZ4
$VRTX Vertex Short Idea (Bearish head and shoulders)Buy put spreads for April on this name. I think 180/165 put debit 4/19 would do well. XBI is under a lot of pressure, this company has nothing fresh right now, massive head and shoulders. Get it back in that safe channelShortby AlphaJiUpdated 5
$VRTX with a neutral outlook following its earnings #Stocks The PEAD projected a neutral outlook following a negative under reaction after its earnings release placing the stock in drift D If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us. by EPSMomentum0
VRTX Beginning!Fundamental & Chart Not for investment advice, personal notes only Chart: identified key area of support, concerning current H&S pattern, potential downside to next support indicate 17% drop. CMF shows weakness, spending a lot of times in the negatives. So far trend line remains intact, neckline of H&S shows no particular bearish inclination Fundamentals: Core product in strong growth, In January 26, 2021, VRTX announced that it received FDA approval for the use of Trikafta with children ages 6-11 with CF and certain mutations. In January 28, 2021, VRTX announced that it received FDA clearance for its type-1 diabetes investigational medicine and will enter the phase ½ clinical trial. Powerful toppling and bottom line growth, Net income has grown 229% from 2019 to September 2020. Currently seeking acquisition opportunities Let's wait and seeLongby jerryz73001221
Head and ShouldersPerfect. Will it work? Rarely does. However, we can track for posterity via TV. Let the games begin.Shortby frodo75Updated 113
$VRTX - Don't start buying just because Cathy woods isClear bearish trend....fundamentals might be right, but as a trader you need to focus on the trend. Shortby CheelooTrader1
(VRTX) Vertex - Upside potential ahead of Earnings releaseVertex is now at levels close to those of Dec'19. Meanwhile, revenues increased +60% QoQ for Q3 2020 and EPS increased + 20% (also QoQ for Q3 2020). Operational cashflows have improved as well. If expected annual earnings are confirmed, Vertex confirms its upside potential and has also a positive outlook ahead as a result of the current environment. Longby HR_DUpdated 6